Arcus Biosciences (RCUS) Other Non-Current Assets (2017 - 2026)

Arcus Biosciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $61.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 14.08% year-over-year to $61.0 million; the TTM figure through Mar 2026 stood at $61.0 million (down 14.08% YoY), while the FY2025 annual figure was $63.0 million, down 13.7% from the prior year.
• Other Non-Current Assets was $61.0 million for Q1 2026 at Arcus Biosciences, down from $63.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $114.0 million in Q4 2022 to a low of $3.0 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $64.4 million across 5 years, with a median of $71.0 million in 2025.
• Biggest YoY gain for Other Non-Current Assets was 3627.12% in 2023; the steepest drop was 94.74% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $114.0 million in 2022, then plunged by 94.74% to $6.0 million in 2023, then surged by 1116.67% to $73.0 million in 2024, then decreased by 13.7% to $63.0 million in 2025, then dropped by 3.17% to $61.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $61.0 million (Q1 2026), $63.0 million (Q4 2025), and $65.0 million (Q3 2025), per Business Quant data.